BMO Raises Price Target On Markit Following Investor Meetings
BMO reiterated its Outperform rating and raised its price target by $2 to $43 on Markit Ltd (NASDAQ: INFO) after the management meetings suggested that the company could achieve its merger synergies earlier than expected.
"While management reiterated its prior targets of $125 million in annualized cost savings and $100 million in annualized revenue synergies by F2019, we believe the slope of reaching these targets could occur earlier than expected," analyst Jeffrey Silber wrote in a note.
Notably, the company has already begun to generate small revenue synergies in just the few weeks as a combined entity.
Silber said management repeated its long-term targets of mid-single-digit revenue growth and low- to mid-40 percent EBITDA margins. In addition, it was "adamant" about hitting its F2017 adjusted EPS goal of 20 percent growth (about $2.08) and mid-teens growth thereafter.
"We believe the combined company is much better protected in the next economic downturn, as the major end-markets — financial services, automotive and energy — may have their own cycles and we likely have already been through the energy downturn," Silber added.
Justification And A Look Ahead
For 2016, Silber projects EPS of $1.75 on revenue of $2.754 billion, and 2017 EPS of $2.05 on revenue of $3.611 billion.
At time of writing, shares of Markit were up 0.85 percent on the day, trading at $36.87. The revised target of $43 implies a potential upside of about 18 percent over Thursday's close.
Full ratings data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
Latest Ratings for INFO
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2022 | Morgan Stanley | Maintains | Overweight | |
Jan 2022 | BMO Capital | Maintains | Market Perform | |
Jan 2022 | Morgan Stanley | Maintains | Overweight |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Analyst Color Long Ideas M&A Price Target Reiteration Analyst Ratings Tech Trading Ideas Best of Benzinga